An Open Label Prospective Study to Evaluate the Efficacy of Entecavir in HBeAg Positive Treatment Naive Chronic Hepatitis –B Patients in A Tertiary Care Centre in Eastern India

Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 6

Abstract

Background: Entecavir is a nucleoside analogue drug that has selective anti-hepatitis B virus (HBV) activity. It is indicated for the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication, persistent elevations in serum aminotransferase and histologically active disease. We conducted a study to evaluate the efficacy of entecavir (ETV) in hepatitis Beantigen (HBeAg) positive- chronic hepatitis B (CHB) treatment naive Indian patients in real life scenario. Method: This is a single center open label prospective observational study to evaluate the efficacy of Entecavir in chronic hepatitis B patients. A total of 140 patients were enrolled in the study from January 2015 to December 2016. Parameters were evaluated at baseline and at 12, 24 and 40 weeks of the treatment, Efficacy of entecavir was assessed by evaluating hepatitis B virus DNA (HBV DNA), serum alanine aminotransferase (ALT) and sero-conversion. Result: The mean HBV DNA at baseline was 5.99 log [on a base-10 scale] IU/mL which decreased to 2.12 log IU/mL at the end of 40 weeks. Thus there was a mean change of 3.87 log IU/ml which was statistically significant (P<0.0001). Out of 140 HBeAg positive subjects, 50 (35.71 %) had become negative at the end of 40 weeks. Only 10.71% of the patients had normal ALT (<40IU/l) values in the beginning which increased to 100% at the end of 40 weeks. Conclusion: Entecavir significantly improves virological, biochemical and serological markers in HBeAg positive treatment naïve chronic hepatitis B patients.

Authors and Affiliations

Jayanta Kumar Panda

Keywords

Related Articles

Flaxseed: Functional Food Components & Therapeutic Role

From the past few years, people are becoming more health conscious and demanding the food having high nutritional value. In this regard, the demand for flaxseed in food and beverages, functional foods and functional attr...

Brucellosis: Presentation, Diagnosis and Treatment: Case Report

Introduction: Brucellosis is one of the commonest zoonotic infections worldwide. the disease is endemic in Saudi Arabia, the Middle East, and the Mediterranean area, and whether in an endemic region or not, it remains a...

Primary Sjӧgren's Syndromewith Granulomatous Interstitial Nephritis

Sjӧgren's syndrome (SS) is a systemic autoimmune disease affecting mainly the exocrine glands. Tubulointerstitial nephritis (TIN) is the most predominant renal involvement with lymphocyte and plasma cells infiltration of...

A Study on Clinical Effects of Grid Laser Photocoagulation in Diabetic Maculopathy

Purpose: To assess the clinical effects of Grid laser photocoagulation in Diabetic macular edema. Materials & Methods: A total of 100 eyes of 50 patients with Diabetic Macular edema attending the Department of Ophthalmol...

Evaluation of Female Infertility by Cyto-Hormonal, Endometrial Biopsy and Endocrinological Study

Objective: The present study was undertaken to know the role of vaginal hormonal cytology, endometrial biopsy and endocrinological evaluation in the detection of ovulation and various ovulatory dysfunction. Material & Me...

Download PDF file
  • EP ID EP285648
  • DOI -
  • Views 79
  • Downloads 0

How To Cite

Jayanta Kumar Panda (2017). An Open Label Prospective Study to Evaluate the Efficacy of Entecavir in HBeAg Positive Treatment Naive Chronic Hepatitis –B Patients in A Tertiary Care Centre in Eastern India. Journal of Medical Science And clinical Research, 5(6), 22810-22815. https://europub.co.uk/articles/-A-285648